Lifestyle foundation: GLP-1 drugs are prescribed as an adjunct to physical workout and a low-calorie diet
For many people with obesity, GLP-1 medications combined with lifestyle changes lead to significantly greater and more sustainable weight loss than lifestyle measures alone
These pathways play a crucial role in its wide-ranging therapeutic effects, extending the benefits of GLP-1RAs beyond metabolic diseases
Retatrutide is an injectable triple agonist that targets GIP (glucose-dependent insulinotropic polypeptide), GLP-1, and glucagon receptors (GCG receptors) simultaneously
Serious Side Effects and When to Contact a Provider Serious side effects are uncommon, but medical guidance is important if you experience: Severe or persistent abdominal pain Ongoing vomiting Signs of dehydration such as confusion or minimal urination Symptoms of low blood sugar, including shakiness, sweating, or rapid heartbeat Prompt communication with your provider helps prevent complications
10.1172/JCI119686 41 MaierM